Top compounds associated with response to AARS


Feature Type Standardized
Nominal ANOVA
mRNA GW-2580 GDSC1000 pan-cancer AAC -0.15 2e-05
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.15 5e-05
mRNA NSC-207895 GDSC1000 pan-cancer AAC -0.13 0.0001
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA neratinib CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.11 0.0003
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA Pyrimethamine GDSC1000 pan-cancer AAC 0.18 0.0008
Download CSV